TriangleEndoscopic Ultrasound (EUS)-Guided… (NCT04990609)
Endoscopic Ultrasound (EUS)-Guided Radiofrequency Ablation (RFA) trial for Pancreatic Ductal Adenocarcinoma (PDAC) (NCT04990609). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for adults with biopsy-confirmed pancreatic ductal adenocarcinoma and no prior chemotherapy or less than two months of preoperative chemotherapy.
The idea: an ultrasound-guided endoscope places an electrode that heats and destroys tumor tissue. Researchers combine repeated ablation with physician-selected chemotherapy before intended surgery. They assess whether patients complete treatment and undergo tumor removal, along with tolerance and treatment effects. Surgery is assessed about five to six months later.
This phase 2 study plans 60 patients. Nirav Thosani leads; Memorial Hermann Hospital, Houston, is the sole recruiting US site.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.